Antidepressant fluoxetine found ineffective for early COVID-19 treatment

Findings reveal fluoxetine’s weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.

PRECISIS GmbH celebrates Win at the Innovation Award of the Federal State Baden-Württemberg 2023 – Biotech Investments

Issuer: PRECISIS GmbH / Key word(s): Miscellaneous 22.11.2023 / 14:57 CET/CEST The issuer is solely responsible for the content of this announcement. Heidelberg, November 22nd

November 23, 2023

Did America’s Trust in Physicians Slide After COVID?

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted

August 4, 2024

What Is Soft Tick Relapsing Fever?

Recurring fever? Consider soft tick relapsing fever (STRF), a Borrelia bacteria infection transmitted to humans by way of soft-bodied ticks that, while rare, has been

July 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.